GXMC
AERI

Global X Management Company’s Aerie Pharmaceuticals AERI Stock Holding History

Global X Management Company’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-909
Closed -$19K – 559
2014
Q1 		$19K Buy
+909
New +$18.4K ﹤0.01% 512

Other funds holding AERI

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Global X Management Company's AERI Position: Q2 2014 in Review

Global X Management Company sold out of Aerie Pharmaceuticals (AERI) in Q2 2014, closing a stake of 909 shares — an estimated $19K sold.

Global X Management Company first reported a position in AERI in Q1 2014 and held it in 1 quarter. The position peaked at $19K in Q1 2014. 60 funds tracked by Wall St. Rank hold AERI as of Q2 2014.

  • Global X Management Company reported no remaining Aerie Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Global X Management Company sold 909 Aerie Pharmaceuticals shares in Q2 2014, an estimated $19K.
  • Global X Management Company first reported a position in Aerie Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Global X Management Company's Aerie Pharmaceuticals position peaked at $19K in Q1 2014.
  • 60 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2014.

Based on Global X Management Company's 13F filing for Q2 2014, filed 31 Jul 2014.